Solventum Receives FDA Clearance for Combined Use of Wound Care Technologies

MT newswire2026/10/19 21:56

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

05:56 PM EDT, 10/19/2026 (MT Newswires) -- Solventum (SOLV) said late Monday it received 510(k) clearance from the US Food and Drug Administration for the combined use of Restrata synthetic electrospun fiber matrix and V.A.C. negative pressure wound therapy to support active wound healing. Restrata matrix provides structural support for soft tissue repair, while V.A.C. Therapy helps create an environment that supports tissue integration. Their combined use may allow for fewer dressing changes and a more predictable workflow for care teams, according to a statement.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

The preliminary November Consumer Sentiment Index from the University of Michigan rose to 51 from 48 in October, surpassing the market's expectation of 48. This improvement was mainly concentrated among independent voters, whose consumer confidence reached a one-year high. About 57% of respondents proactively mentioned that high prices are affecting their standard of living, the highest percentage since May. Consumers expect prices to rise by 4.3% over the next year, the lowest level in three months.

华尔街见闻•2026/11/06 17:07